Schlesinger, Naomi
Article History
First Online: 9 September 2016
Competing interests
: The author declares that she has received grants from AstraZeneca; is a member of the advisory boards for Pfizer, AstraZeneca, ProteoThera, Celgene and Horizon Pharma; is a member of a speakers' bureau for Novartis and Takeda; and is a consultant for Novartis, Sobi and BMS.